Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

1.5K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.5K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

1.8K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.8K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

1.3K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.3K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

1.1K
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
1.1K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

2.4K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.4K
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

43
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The protease inhibitor darunavir prevents esophagitis and impairments in esophageal barrier function in a mouse model of GERD.

American journal of physiology. Gastrointestinal and liver physiology·2026
Same author

Gastroesophageal Reflux Disease (Japanese Version).

Annals of internal medicine·2026
Same author

Why VA GI?

Digestive diseases and sciences·2025
Same author

In Obesity, Esophagogastric Junction Fat Impairs Esophageal Barrier Function and Dilates Intercellular Spaces via Hypoxia-Inducible Factor 2α.

Gastroenterology·2024
Same author

A Crisis in Scope: Recruitment and Retention Challenges Reported by VA Gastroenterology Section Chiefs.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2024
Same author

Gastroesophageal Reflux Disease.

Annals of internal medicine·2024

Related Experiment Video

Updated: Apr 29, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K

Controversies in Barrett esophagus.

Kerry B Dunbar1, Stuart Jon Spechler1

  • 1Department of Medicine, VA North Texas Healthcare System, and the Department of Medicine, Division of Gastroenterology and Hepatology, University of Texas Southwestern Medical Center at Dallas.

Mayo Clinic Proceedings
|May 29, 2014
PubMed
Summary

Barrett esophagus diagnosis requires intestinal metaplasia. Current surveillance may not prevent cancer deaths, and screening rationale is debated, questioning its benefit for patients with Barrett esophagus.

More Related Videos

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

10.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

971

Related Experiment Videos

Last Updated: Apr 29, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

10.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

971

Area of Science:

  • Gastroenterology
  • Oncology
  • Gastrointestinal Surgery

Background:

  • Barrett esophagus involves esophageal squamous epithelium replaced by metaplastic columnar epithelium due to gastroesophageal reflux disease.
  • Intestinal metaplasia with goblet cells is the current US diagnostic standard for Barrett esophagus.
  • Esophageal adenocarcinoma incidence is rising despite low annual cancer risk (0.12%-0.38%) in nondysplastic Barrett esophagus.

Purpose of the Study:

  • To review controversies in Barrett esophagus management.
  • To evaluate the efficacy of current surveillance and screening strategies.
  • To discuss the role of endoscopic ablation for Barrett esophagus.

Main Methods:

  • Literature review of studies on Barrett esophagus, ablation, dysplasia, radiofrequency ablation, and endoscopic mucosal resection.
  • Analysis of data regarding cancer risk, surveillance benefits, and screening rationale.
  • Discussion of controversial aspects impacting clinical practice.

Main Results:

  • High-quality studies suggest endoscopic surveillance may not prevent cancer deaths in Barrett esophagus patients.
  • The benefit of endoscopic screening for Barrett esophagus is questioned due to uncertain surveillance efficacy.
  • Efficacy of endoscopic eradication for nondysplastic Barrett esophagus is questionable for cancer prevention.

Conclusions:

  • The rationale for screening and surveillance in Barrett esophagus requires re-evaluation.
  • Endoscopic ablation's role in preventing cancer from nondysplastic Barrett esophagus is uncertain.
  • Clinical practice for Barrett esophagus is affected by ongoing controversies regarding diagnosis and treatment.